RxDoctor Payments Data

Michael Kraft, MD

Sports Medicine · Atlanta, GANPI 1558657080

Payments from drug & device makers

$1,063in general payments, 2019–2025

Across 62 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$294
  • Novo Nordisk$212
  • Abbott$199
  • Exact Sciences$54
  • Lilly USA, LLC$47
  • AstraZeneca$46
  • plus $210 from 9 others

What the payments were for

  • Food & beverage$1,063100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,063 in reported general payments places this provider in the 50th percentile of 168 sports medicine providers in Georgia.

See all sports medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$31,991
Medicare patients
122
Services billed
447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide30$30,828
JardianceEmpagliflozin22$25,018
EliquisApixaban16$22,168
OzempicSemaglutide13$16,201
JanuviaSitagliptin Phosphate12$15,281
XareltoRivaroxaban19$12,740
TrulancePlecanatide12$6,586
MyrbetriqMirabegron11$5,814
Warfarin Sodium308$3,732
Enoxaparin Sodium28$2,971
Duloxetine Hcl51$1,828
SynthroidLevothyroxine Sodium11$1,518
Ipratropium Bromide64$1,352
Estradiol21$922
Celecoxib18$854

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$47$30,82830 claims
Novo NordiskOzempic$212$16,20113 claims
Astellas Pharma US IncMyrbetriq$14$5,81411 claims
AbbVieSynthroid$294$1,51811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 168 sports medicine providers in Georgia.

Other sports medicine in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →